HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kosei Yasumoto Selected Research

Kosei Yasumoto Research Topics

Disease

59Neoplasms (Cancer)
11/2020 - 01/2002
41Lung Neoplasms (Lung Cancer)
11/2020 - 03/2002
27Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2011 - 01/2002
11Neoplasm Metastasis (Metastasis)
08/2020 - 06/2002
10Adenocarcinoma
10/2011 - 09/2005
8Adenocarcinoma of Lung
11/2020 - 05/2006
8Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2011 - 09/2005
6Carcinoma (Carcinomatosis)
01/2009 - 04/2003
5Colorectal Neoplasms (Colorectal Cancer)
08/2020 - 06/2002
4Melanoma (Melanoma, Malignant)
09/2009 - 07/2002
3Neoplasm Micrometastasis
12/2010 - 01/2002
3Lymphatic Metastasis
08/2009 - 10/2006
3Large Cell Carcinoma
03/2007 - 09/2005
3Esophageal Neoplasms (Esophageal Cancer)
09/2005 - 05/2005
2Testicular Neoplasms (Testicular Cancer)
01/2018 - 04/2010
2Fistula
09/2011 - 08/2010
2Myasthenia Gravis
09/2010 - 01/2009
2Malignant Mesothelioma
07/2010 - 07/2009
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
07/2009 - 09/2007
2Esophageal Squamous Cell Carcinoma
05/2009 - 07/2007
2Carcinogenesis
05/2006 - 07/2005
2Disease Progression
12/2005 - 01/2005
1Endometrial Neoplasms (Endometrial Cancer)
08/2020
1Neuroendocrine Carcinoma
08/2020
1Uterine Cervical Neoplasms (Cancer of the Cervix)
08/2020
1Uterine Neoplasms (Uterine Cancer)
08/2020
1Colonic Neoplasms (Colon Cancer)
04/2011
1Hyperthermia
03/2011

Drug/Important Bio-Agent (IBA)

18AntigensIBA
11/2020 - 03/2002
12ErbB Receptors (EGF Receptor)IBA
12/2011 - 01/2006
12Proteins (Proteins, Gene)FDA Link
12/2010 - 01/2002
8Gefitinib (Iressa)FDA Link
11/2010 - 01/2006
8Neoplasm Antigens (Tumor Antigens)IBA
01/2010 - 03/2002
6Peptides (Polypeptides)IBA
11/2020 - 04/2004
6ParaffinIBA
12/2010 - 10/2004
5Immunoglobulin G (IgG)IBA
07/2010 - 03/2002
5Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
05/2008 - 03/2003
4Tyrosine Kinase InhibitorsIBA
12/2011 - 12/2006
4Messenger RNA (mRNA)IBA
04/2011 - 08/2002
4Cisplatin (Platino)FDA LinkGeneric
11/2010 - 08/2002
4Biological ProductsIBA
08/2009 - 03/2005
3AsbestosIBA
07/2010 - 04/2003
3Indicators and Reagents (Reagents)IBA
05/2009 - 12/2004
3Estrogens (Estrogen)FDA Link
01/2009 - 07/2007
3CytokinesIBA
12/2007 - 02/2002
3CytochromesIBA
05/2007 - 12/2002
3HLA-A24 AntigenIBA
03/2007 - 05/2005
3Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2007 - 12/2002
3Tumor Biomarkers (Tumor Markers)IBA
03/2005 - 01/2003
3Keratins (Keratin)IBA
07/2003 - 01/2002
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
12/2011 - 05/2010
2Estrogen Receptor betaIBA
03/2011 - 01/2009
2Estrogen ReceptorsIBA
03/2011 - 01/2009
2Biomarkers (Surrogate Marker)IBA
03/2011 - 07/2010
2Erlotinib Hydrochloride (CP 358,774)FDA Link
11/2010 - 07/2007
2Paclitaxel (Taxol)FDA LinkGeneric
11/2010 - 07/2010
2Carboplatin (JM8)FDA LinkGeneric
11/2010 - 07/2010
2HLA Antigens (Human Leukocyte Antigens)IBA
10/2010 - 11/2007
2HLA-A Antigens (HLA-A)IBA
01/2010 - 03/2007
2VaccinesIBA
09/2009 - 05/2005
2AntibodiesIBA
07/2009 - 03/2002
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2009 - 01/2006
2Aromatase (CYP19)IBA
01/2009 - 05/2008
2EnzymesIBA
05/2008 - 02/2002
2Transcription Factors (Transcription Factor)IBA
12/2007 - 11/2004
2Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA
05/2007 - 01/2007
2Cytochrome P-450 CYP1A1 (CYP1A1)IBA
01/2007 - 03/2003
2Cytochrome P-450 CYP3AIBA
01/2007 - 05/2005
2Carcinoembryonic AntigenIBA
10/2006 - 03/2005
2Complementary DNA (cDNA)IBA
09/2006 - 03/2002
2Histidine (L-Histidine)FDA Link
05/2006 - 05/2006
2PhytohemagglutininsIBA
05/2006 - 07/2005
2Amino AcidsFDA Link
05/2006 - 04/2004
1HLA-B15 AntigenIBA
11/2020
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
02/2012
1antigen CYFRA21.1IBA
10/2011
1Fibrin Tissue Adhesive (Fibrin Sealant)IBA
09/2011
1RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA
04/2011
1Therapeutic UsesIBA
03/2011
1Cadherins (E-Cadherin)IBA
12/2010
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
12/2010
1Vascular Endothelial Growth Factor CIBA
12/2010
1alpha Catenin (alpha E-Catenin)IBA
12/2010
1gamma Catenin (Plakoglobin)IBA
12/2010
1beta CateninIBA
12/2010
1GemcitabineFDA Link
11/2010

Therapy/Procedure

11Immunotherapy
01/2020 - 07/2002
9Therapeutics
08/2020 - 06/2002
7Drug Therapy (Chemotherapy)
08/2020 - 05/2005
4Adjuvant Chemotherapy
01/2013 - 03/2010
3Cell- and Tissue-Based Therapy (Cell Therapy)
08/2020 - 08/2020
3Radiotherapy
03/2011 - 01/2009
2Heterologous Transplantation (Xenotransplantation)
11/2020 - 07/2009
2Segmental Mastectomy (Lumpectomy)
01/2013 - 01/2011
2Ligation
08/2010 - 05/2008
2Lymph Node Excision (Lymph Node Dissection)
03/2010 - 06/2002
1Hepatectomy
01/2017
1Conservative Treatment
09/2011
1Thoracotomy
04/2011
1Aftercare (After-Treatment)
03/2011